\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:\\ t\\ 98\\.4\\ hr\\ \\ \\ \\ bp\\ \\ \\ \\ \\ rr\\ \\ \\ \\ o2\\ sat\\ 98\\%\\ on\\ ra\\ wt\\ 15\\.2\\ kg\\ ht\\ 44cm\\ \ \(0\)\
\-\ gen\\:\\ small\\ for\\ age\\;\\ normal\\ activity\\ for\\ age\\,\\ alert\\ and\\ responsive\\,\ \(0\)\
\-\ heent\\:\\ left\\ tm\\ well\\ visualized\\ with\\ good\\ light\\ reflex\\;\\ right\\ tm\\ occluded\\ by\\ cerumen\\ \\(unable\\ to\\ extract\\ at\\ this\\ time\\)\\;\\ eomi\\,\\ perrla\\,\\ no\\ nasal\\ discharge\\,\\ oropharynx\\ clear\\ and\\ w\\/o\\ exudates\\ or\\ erythema\\,\\ no\\ lad\\ appreciated\ \(0\)\
\-\ cv\\:\\ reg\\ rate\\ and\\ rhythm\\,\\ no\\ murmurs\\,\\ rubs\\,\\ or\\ gallops\\ appreciated\ \(0\)\
\-\ resp\\:\\ ctab\ \(0\)\
\-\ gi\\:\\ \\ normoactive\\ bowel\\ sounds\\,\\ ntnd\\,\\ no\\ hsm\\,\\ no\\ masses\ \(0\)\
\-\ ext\\:\\ from\\,\\ no\\ edema\ \(0\)\
\-\ skin\\:\\ warm\\,\\ dry\\,\\ no\\ lesions\\,\\ no\\ bruises\ \(0\)\
\-\ neuro\\:\\ grossly\\ intact\ \(0\)\
\-\ labs\ \(154\)\
\-\ normal\\:\\ c3\\,\\ igg\\,\\ iga\\,\\ igm\\,\\ ige\\,\\ rheumatoid\\ factor\\,\\ esr\\,\\ ch50\\,\\ gbm\\ ab\\,\\ ace\\,\\ anca\\,\ \(0\)\
\-\ low\\ fe\\,\\ elevated\\ ferritin\\ and\\ tibc\ \(0\)\
\-\ patient\\ is\\ presently\\ receiving\\ monthly\\ ivig\\ \\(2mg\\/kg\\)\\ infusions\\ with\\ pretreatment\\ of\\ tylenol\\ 15mg\\/kg\\ \\ and\\ concurrent\\ steroid\\ bursts\\ \\(solumedrol\\ 30mg\\/kg\\)\\.\\ will\\ reassess\\ with\\ ct\\,\\ pfts\\ every\\ 6\\ months\\.\ \(0\)\
\-\ literature\\ review\\ shows\\ current\\ recommendations\\ as\\ follows\\:\ \(0\)\
\-\ \\*\\ systemic\\ glucocorticoids\\ \\-\\ noted\\ improvement\\ during\\ acute\\ phase\\ but\\ unclear\\ effects\\ during\\ resolution\\.\\ studies\\ suggest\\ fewer\\ exacerbations\\ and\\ possible\\ decrease\\ in\\ fibrogenesis\\.\\ oral\\ \\>\\>\\ inhaled\\.\\ generally\\ starting\\ dose\\ recommended\\ \\<1mg\\/kg\\/day\ \(0\)\
\-\ \\*\\ immunosuppression\\ as\\ adjunct\\ to\\ steroid\\ treatment\\ \\(most\\ supporting\\ evidence\\ for\\ decreased\\ excarebations\\)\\:\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ azathriopine\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ cyclophosphamide\ \(0\)\
\-\ \\*\\ ivig\ \(0\)\
\-\ \\*\\ tranfusions\\ for\\ anemia\ \(0\)\
\-\ during\\ acute\\ bleeding\\ episode\\,\\ areas\\ of\\ increased\\ opacity\\ and\\ decreased\\ lung\\ volume\\ are\\ seen\\ throughout\\ the\\ lungs\\,\\ especially\\ in\\ the\\ bases\\.\ \(0\)\
\-\ idiopathic\\ pulmonary\\ hemosiderosis\ \(3\)\
\-\ ddx\\ for\\ diffuse\\ alveolar\\ hemorrhage\\:\\ \ \(0\)\
\-\ immune\\ related\\-\\ anti\\-basement\\ membrane\\ antibody\\ disease\\ \\(goodpasture\\'s\\ syndrome\\)\\,\\ vasculitis\\ and\\ collagen\\ vascular\\ disease\\ \\(systemic\\ lupus\\ erythematosus\\,\\ wegener\\'s\\ granulomatosis\\,\\ systemic\\ necrotizing\\ vasculitis\\,\\ and\\ others\\)\\,\\ and\\ pulmonary\\ capillaritis\\ associated\\ with\\ idiopathic\\ rapidly\\ progressive\\ glomerulonephritis\\.\\ \ \(0\)\
\-\ nonimmune\\-coagulopathy\\,\\ necrotizing\\ pulmonary\\ infection\\,\\ drugs\\ \\(penicillamine\\)\\,\\ toxins\\ \\(trimellitic\\ anhydride\\)\\,\\ heiner\\â\\€\\™s\\ syndrome\\,\\ and\\ idiopathic\\ pulmonary\\ hemosiderosis\ \(0\)\
\-\ patient\\ with\\ diagnosis\\ of\\ idiopathic\\ pulmonary\\ hemosiderosis\\ per\\ open\\ lung\\ biopsy\\ 10\\/07\\ who\\ has\\ been\\ relatively\\ asymptomatic\\ but\\ with\\ persistent\\ presence\\ of\\ hemosiderin\\-laden\\ macrophages\\ in\\ bronchoalveolar\\ lavage\\ and\\ desaturation\\ noted\\ on\\ exercise\\ test\\ in\\ may\\ 2008\\.\\ \ \(0\)\
\-\ history\ \(2609\)\
\-\ patient\\ was\\ product\\ of\\ pregnancy\\ complicated\\ by\\ pre\\-eclampsia\\.\\ patient\\ was\\ born\\ at\\ 27weeks\\ after\\ 2\\ days\\ of\\ antenatal\\ steroids\\.\\ significant\\ respiratory\\ distress\\ requiring\\ intubation\\ was\\ noted\\ immediately\\ after\\ birth\\.\\ \ \(0\)\
\-\ neonatal\\ course\\ included\\ multiple\\ doses\\ of\\ surfactant\\.\\ 68\\ days\\ mechanical\\ ventilation\\,\\ and\\ 3\\ months\\ of\\ nicu\\ care\\.\\ complications\\ included\\ multiple\\ episodes\\ of\\ pneumonia\\,\\ presumed\\ sepsis\\,\\ nec\\,\\ anemia\\,\\ and\\ electrolyte\\ abnormalities\\.\\ \ \(0\)\
\-\ the\\ patient\\ was\\ discharged\\ home\\ on\\ o2\\ which\\ she\\ used\\ until\\ 9\\ months\\ of\\ age\\,\\ as\\ well\\ as\\ fe\\,\\ diuretics\\,\\ steroids\\.\ \(0\)\
\-\ after\\ 1\\ year\\ of\\ age\\,\\ patient\\ began\\ to\\ have\\ multiple\\ episodes\\ of\\ pneumonia\\,\\ bronchitis\\,\\ and\\ asthma\\ requiring\\ hospitalization\\.\\ anemia\\,\\ requiring\\ 2\\ transfusions\\,\\ was\\ noted\\ in\\ context\\ of\\ one\\ episode\\ of\\ pneumonia\\.\\ \ \(0\)\
\-\ in\\ addition\\,\\ the\\ patient\\ experienced\\ failure\\ to\\ thrive\\,\\ reaching\\ less\\ than\\ 3\\%\\ height\\/weight\\ for\\ her\\ age\\.\ \(0\)\
\-\ at\\ the\\ present\\,\\ the\\ patient\\ is\\ at\\ 25\\%\\ height\\,\\ 3\\%\\ weight\\.\ \(0\)\
\-\ parents\\ otherwise\\ deny\\ recent\\ uri\\,\\ cough\\,\\ wheeze\\.\ \(0\)\
\-\ hospitalizations\\:\\ \ \(0\)\
\-\ after\\ birth\\ x\\ 3\\ mos\ \(1\)\
\-\ 2004\\-pna\ \(1\)\
\-\ 2005\\-pna\\ and\\ transfusion\\ for\\ anemia\ \(1\)\
\-\ 2006\\-pulmonary\\ hemorrhage\\,\\ respiratory\\ failure\ \(1\)\
\-\ 2007\\-multifocal\\ pna\ \(1\)\
\-\ surgeries\\:\ \(0\)\
\-\ bronchoscopy\\ 12\\/06\\,\\ 12\\/07\\,\\ 5\\/08\ \(1\)\
\-\ open\\ lung\\ bx\\ 10\\/07\ \(1\)\
\-\ port\\ cath\\ placement\\ 12\\/07\ \(1\)\
\-\ meds\\:\\ \ \(0\)\
\-\ prevacid\\ 15\\ mg\\ tablet\\ qd\ \(0\)\
\-\ miralax\\,\\ 17\\ gm\\ qd\ \(0\)\
\-\ iron\\ oral\\ solution75mg\\/0\\.6ml\\-\\ 25\\ mg\\/ml\ \(0\)\
\-\ hydroxychloroquine\\ 25mg\\/ml\\-\\ 6ml\\ qd\ \(0\)\
\-\ tums\\ \\â\\€\\“\\ 1\\ tablet\\ qd\\ for\\ calcium\ \(0\)\
\-\ flinstones\\ mvt\\ \ \(0\)\
\-\ immunizations\\:\\ up\\ to\\ date\ \(0\)\
\-\ allergies\\:\\ cow\\â\\€\\™s\\ milk\\ \ \(0\)\
\-\ developmental\\ history\\:\\ delayed\\ fine\\ motor\\ skills\\ per\\ mop\\;\\ otherwise\\ met\\ all\\ milestones\\.\\ \ \(0\)\
\-\ family\\ history\\:\\ non\\-contributory\ \(0\)\
\-\ social\\ history\\:\\ lives\\ with\\ mother\\,\\ father\\,\\ older\\ brother\\.\\ no\\ pets\\,\\ no\\ smoking\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\:\\:\\ 0\\.03395675412847492\ \(0\)\
\-\ qd\\:\\ 0\\.032260169348317894\ \(0\)\
\-\ hemosiderosis\\:\\ 0\\.030927384169666942\ \(0\)\
\-\ \\*\\:\\ 0\\.027210731979514045\ \(0\)\
\-\ \\,\\:\\ 0\\.025947888969468175\ \(0\)\
\-\ 10\\/07\\:\\ 0\\.025223228680876963\ \(0\)\
\-\ 12\\/07\\:\\ 0\\.025223228680876963\ \(0\)\
\-\ anemia\\:\\ 0\\.024327154406287053\ \(0\)\
\-\ ivig\\:\\ 0\\.02323997494536925\ \(0\)\
\-\ idiopathic\\:\\ 0\\.022292060075183823\ \(0\)\
\-\ fe\\:\\ 0\\.021256721209861537\ \(0\)\
\-\ requiring\\:\\ 0\\.020262548762851492\ \(0\)\
\-\ tablet\\:\\ 0\\.018635002377603585\ \(0\)\
\-\ age\\:\\ 0\\.018604508766411346\ \(0\)\
\-\ pulmonary\\:\\ 0\\.01785801366394895\ \(0\)\
\-\ systemic\\:\\ 0\\.017545624915253896\ \(0\)\
\-\ tm\\:\\ 0\\.01637904426497334\ \(0\)\
\-\ pneumonia\\:\\ 0\\.015160148906560127\ \(0\)\
\-\ necrotizing\\:\\ 0\\.014268603798218607\ \(0\)\
\-\ o2\\:\\ 0\\.014030029809837917\ \(0\)\
\-\ steroid\\:\\ 0\\.012908307098032413\ \(0\)\
\-\ 44cm\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ extract\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ ch50\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 2mg\\/kg\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 15mg\\/kg\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 30mg\\/kg\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ fibrogenesis\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 1mg\\/kg\\/day\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ excarebations\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ azathriopine\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ related\\-\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ anti\\-basement\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ nonimmune\\-coagulopathy\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ penicillamine\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ trimellitic\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ anhydride\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ heiner\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ hemosiderin\\-laden\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 27weeks\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ height\\/weight\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 2004\\-pna\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 2005\\-pna\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 2006\\-pulmonary\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 2007\\-multifocal\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 12\\/06\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 5\\/08\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ solution75mg\\/0\\.6ml\\-\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ mg\\/ml\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 25mg\\/ml\\-\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ 6ml\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ flinstones\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ mvt\\:\\ 0\\.012611614340438481\ \(0\)\
\-\ vasculitis\\:\\ 0\\.012511780164452594\ \(0\)\
\-\ no\\:\\ 0\\.012309644502200314\ \(0\)\
\-\ episode\\:\\ 0\\.01210458067323584\ \(0\)\
\-\ episodes\\:\\ 0\\.012075532400091297\ \(0\)\
\-\ appreciated\\:\\ 0\\.011907176176849714\ \(0\)\
\-\ birth\\:\\ 0\\.011748178033345248\ \(0\)\
\-\ reg\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ ntnd\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ bursts\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ tranfusions\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ capillaritis\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ deny\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ prevacid\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ miralax\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ tums\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ mop\\:\\ 0\\.011619987472684626\ \(0\)\
\-\ \\;\\:\\ 0\\.011590393066967632\ \(0\)\
\-\ noted\\:\\ 0\\.011590393066967632\ \(0\)\
\-\ steroids\\:\\ 0\\.011501367320085141\ \(0\)\
\-\ 3\\:\\ 0\\.011450503729365034\ \(0\)\
\-\ \\%\\:\\ 0\\.011406701192251833\ \(0\)\
\-\ included\\:\\ 0\\.011274166239671951\ \(0\)\
\-\ during\\:\\ 0\\.011223215664909048\ \(0\)\
\-\ exudates\\:\\ 0\\.011039922940341042\ \(0\)\
\-\ solumedrol\\:\\ 0\\.011039922940341042\ \(0\)\
\-\ 2008\\.\\:\\ 0\\.011039922940341042\ \(0\)\
\-\ cow\\:\\ 0\\.011039922940341042\ \(0\)\
\-\ pets\\:\\ 0\\.011039922940341042\ \(0\)\
\-\ open\\:\\ 0\\.010867635442493773\ \(0\)\
\-\ per\\:\\ 0\\.010701987435572735\ \(0\)\
\-\ 98\\.4\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ 15\\.2\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ cerumen\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ anca\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ pretreatment\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ goodpasture\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ pna\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ hydroxychloroquine\\:\\ 0\\.010628360604930769\ \(0\)\
\-\ lung\\:\\ 0\\.010623000516046121\ \(0\)\
\-\ ige\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ tibc\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ infusions\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ reassess\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ pre\\-eclampsia\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ cath\\:\\ 0\\.010309128056555648\ \(0\)\
\-\ oral\\:\\ 0\\.010302096327203183\ \(0\)\
\-\ respiratory\\:\\ 0\\.010150673147076308\ \(0\)\
\-\ after\\:\\ 0\\.01011731732537455\ \(0\)\
\-\ months\\:\\ 0\\.010016915427854366\ \(0\)\
\-\ 25\\:\\ 0\\.009883336933496632\ \(0\)\
\-\ ferritin\\:\\ 0\\.009827765772405128\ \(0\)\
\-\ inhaled\\:\\ 0\\.009827765772405128\ \(0\)\
\-\ immunosuppression\\:\\ 0\\.009827765772405128\ \(0\)\
\-\ toxins\\:\\ 0\\.009827765772405128\ \(0\)\
\-\ nec\\:\\ 0\\.009827765772405128\ \(0\)\
\-\ patient\\:\\ 0\\.009803627249400721\ \(0\)\
\-\ pfts\\:\\ 0\\.009636733737176913\ \(0\)\
\-\ desaturation\\:\\ 0\\.009636733737176913\ \(0\)\
\-\ surfactant\\:\\ 0\\.009636733737176913\ \(0\)\
\-\ diuretics\\:\\ 0\\.009636733737176913\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.009636733737176913\ \(0\)\
\-\ failure\\:\\ 0\\.009577849164038246\ \(0\)\
\-\ iga\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ presently\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ fewer\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ bx\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ gm\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ immunizations\\:\\ 0\\.009468231540243602\ \(0\)\
\-\ exacerbations\\:\\ 0\\.009317501188801793\ \(0\)\
\-\ antenatal\\:\\ 0\\.009317501188801793\ \(0\)\
\-\ wheeze\\:\\ 0\\.009317501188801793\ \(0\)\
\-\ milk\\:\\ 0\\.009317501188801793\ \(0\)\
\-\ monthly\\:\\ 0\\.009181149000240526\ \(0\)\
\-\ electrolyte\\:\\ 0\\.009181149000240526\ \(0\)\
\-\ skills\\:\\ 0\\.009181149000240526\ \(0\)\
\-\ milestones\\:\\ 0\\.009181149000240526\ \(0\)\
\-\ hsm\\:\\ 0\\.009056669204833329\ \(0\)\
\-\ bruises\\:\\ 0\\.009056669204833329\ \(0\)\
\-\ glomerulonephritis\\:\\ 0\\.009056669204833329\ \(0\)\
\-\ context\\:\\ 0\\.009056669204833329\ \(0\)\
\-\ igm\\:\\ 0\\.008942158893426267\ \(0\)\
\-\ adjunct\\:\\ 0\\.008942158893426267\ \(0\)\
\-\ supporting\\:\\ 0\\.008942158893426267\ \(0\)\
\-\ glucocorticoids\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ macrophages\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ lavage\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ bronchitis\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ mos\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ brother\\:\\ 0\\.008836138904651273\ \(0\)\
\-\ otherwise\\:\\ 0\\.008782017835268512\ \(0\)\
\-\ bronchoalveolar\\:\\ 0\\.008737436656458208\ \(0\)\
\-\ doses\\:\\ 0\\.008737436656458208\ \(0\)\
\-\ uri\\:\\ 0\\.008645106869423057\ \(0\)\
\-\ normoactive\\:\\ 0\\.00855837636610913\ \(0\)\
\-\ ace\\:\\ 0\\.00855837636610913\ \(0\)\
\-\ reaching\\:\\ 0\\.00855837636610913\ \(0\)\
\-\ met\\:\\ 0\\.00855837636610913\ \(0\)\
\-\ concurrent\\:\\ 0\\.008476604672489748\ \(0\)\
\-\ product\\:\\ 0\\.008476604672489748\ \(0\)\
\-\ transfusions\\:\\ 0\\.008476604672489748\ \(0\)\
\-\ thrive\\:\\ 0\\.008476604672489748\ \(0\)\
\-\ igg\\:\\ 0\\.008399255285836993\ \(0\)\
\-\ for\\:\\ 0\\.008344585392191304\ \(0\)\
\-\ ht\\:\\ 0\\.008325874321047935\ \(0\)\
\-\ lad\\:\\ 0\\.008325874321047935\ \(0\)\
\-\ erythematosus\\:\\ 0\\.008325874321047935\ \(0\)\
\-\ lives\\:\\ 0\\.008325874321047935\ \(0\)\
\-\ \\(\\:\\ 0\\.008267373118670793\ \(0\)\
\-\ resp\\:\\ 0\\.008256074372307689\ \(0\)\
\-\ ab\\:\\ 0\\.008256074372307689\ \(0\)\
\-\ tylenol\\:\\ 0\\.008256074372307689\ \(0\)\
\-\ transfusion\\:\\ 0\\.008256074372307689\ \(0\)\
\-\ port\\:\\ 0\\.008256074372307689\ \(0\)\
\-\ \\)\\:\\ 0\\.008166382742355423\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.008138073202220417\ \(0\)\
\-\ responsive\\:\\ 0\\.008125928766863159\ \(0\)\
\-\ recommendations\\:\\ 0\\.008125928766863159\ \(0\)\
\-\ immune\\:\\ 0\\.008125928766863159\ \(0\)\
\-\ antibody\\:\\ 0\\.008125928766863159\ \(0\)\
\-\ \\>\\:\\ 0\\.00812351220219904\ \(0\)\
\-\ kg\\:\\ 0\\.007896540140146164\ \(0\)\
\-\ occluded\\:\\ 0\\.007896540140146164\ \(0\)\
\-\ perrla\\:\\ 0\\.007896540140146164\ \(0\)\
\-\ \\-\\:\\ 0\\.007861495530937183\ \(0\)\
\-\ wt\\:\\ 0\\.007844512036897417\ \(0\)\
\-\ warm\\:\\ 0\\.007794309862632366\ \(0\)\
\-\ unclear\\:\\ 0\\.007794309862632366\ \(0\)\
\-\ starting\\:\\ 0\\.007794309862632366\ \(0\)\
\-\ wegener\\:\\ 0\\.007794309862632366\ \(0\)\
\-\ intubation\\:\\ 0\\.007794309862632366\ \(0\)\
\-\ c3\\:\\ 0\\.007745809788704353\ \(0\)\
\-\ multiple\\:\\ 0\\.007724489285318751\ \(0\)\
\-\ iron\\:\\ 0\\.0076989001709318345\ \(0\)\
\-\ oropharynx\\:\\ 0\\.007653480001669201\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.007653480001669201\ \(0\)\
\-\ nicu\\:\\ 0\\.007653480001669201\ \(0\)\
\-\ hospitalization\\:\\ 0\\.007609457600143087\ \(0\)\
\-\ 98\\:\\ 0\\.007566749498355274\ \(0\)\
\-\ ctab\\:\\ 0\\.007566749498355274\ \(0\)\
\-\ eomi\\:\\ 0\\.007525279488522295\ \(0\)\
\-\ sepsis\\:\\ 0\\.007525279488522295\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.007525279488522295\ \(0\)\
\-\ meds\\:\\ 0\\.007525279488522295\ \(0\)\
\-\ days\\:\\ 0\\.00749377481022025\ \(0\)\
\-\ ext\\:\\ 0\\.007484977804735892\ \(0\)\
\-\ ventilation\\:\\ 0\\.007445780416770062\ \(0\)\
\-\ as\\:\\ 0\\.007396723925002162\ \(0\)\
\-\ neonatal\\:\\ 0\\.00733424745329408\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.007307658768656526\ \(0\)\
\-\ gallops\\:\\ 0\\.007298921827270659\ \(0\)\
\-\ alveolar\\:\\ 0\\.007298921827270659\ \(0\)\
\-\ father\\:\\ 0\\.007298921827270659\ \(0\)\
\-\ decreased\\:\\ 0\\.007269689278181858\ \(0\)\
\-\ dry\\:\\ 0\\.007264447504553833\ \(0\)\
\-\ surgeries\\:\\ 0\\.007264447504553833\ \(0\)\
\-\ gbm\\:\\ 0\\.0072307844181300936\ \(0\)\
\-\ lupus\\:\\ 0\\.007197895264732814\ \(0\)\
\-\ others\\:\\ 0\\.007197895264732814\ \(0\)\
\-\ membrane\\:\\ 0\\.0071657452563607706\ \(0\)\
\-\ allergies\\:\\ 0\\.0071657452563607706\ \(0\)\
\-\ effects\\:\\ 0\\.0071343018991093035\ \(0\)\
\-\ social\\:\\ 0\\.0071343018991093035\ \(0\)\
\-\ parents\\:\\ 0\\.007103534795788898\ \(0\)\
\-\ receiving\\:\\ 0\\.007073415469325619\ \(0\)\
\-\ was\\:\\ 0\\.0070692240501694335\ \(0\)\
\-\ fine\\:\\ 0\\.007043917204371776\ \(0\)\
\-\ rubs\\:\\ 0\\.007015014904918958\ \(0\)\
\-\ s\\:\\ 0\\.00701221077858251\ \(0\)\
\-\ syndrome\\:\\ 0\\.006992579618697115\ \(0\)\
\-\ bases\\:\\ 0\\.006986684966011692\ \(0\)\
\-\ sat\\:\\ 0\\.0069589051579185554\ \(0\)\
\-\ collagen\\:\\ 0\\.0069589051579185554\ \(0\)\
\-\ 68\\:\\ 0\\.006931654521336734\ \(0\)\
\-\ presumed\\:\\ 0\\.006931654521336734\ \(0\)\
\-\ w\\/o\\:\\ 0\\.006904913272392309\ \(0\)\
\-\ cv\\:\\ 0\\.006778227439285806\ \(0\)\
\-\ rapidly\\:\\ 0\\.006778227439285806\ \(0\)\
\-\ drugs\\:\\ 0\\.006754182920950497\ \(0\)\
\-\ mechanical\\:\\ 0\\.006754182920950497\ \(0\)\
\-\ asthma\\:\\ 0\\.006754182920950497\ \(0\)\
\-\ history\\:\\ 0\\.006753731260126372\ \(0\)\
\-\ gen\\:\\ 0\\.006730535850920153\ \(0\)\
\-\ mg\\:\\ 0\\.006707273303177978\ \(0\)\
\-\ ra\\:\\ 0\\.0066843829722102515\ \(0\)\
\-\ reflex\\:\\ 0\\.006661853133915345\ \(0\)\
\-\ at\\:\\ 0\\.006625254093457127\ \(0\)\
\-\ murmurs\\:\\ 0\\.006575122630601418\ \(0\)\
\-\ literature\\:\\ 0\\.006575122630601418\ \(0\)\
\-\ follows\\:\\ 0\\.006575122630601418\ \(0\)\
\-\ every\\:\\ 0\\.0064933509369820355\ \(0\)\
\-\ ddx\\:\\ 0\\.006454153549016206\ \(0\)\
\-\ height\\:\\ 0\\.006434950372575377\ \(0\)\
\-\ grossly\\:\\ 0\\.006416001550329281\ \(0\)\
\-\ dose\\:\\ 0\\.0063973004322071736\ \(0\)\
\-\ born\\:\\ 0\\.006378840625574974\ \(0\)\
\-\ rhythm\\:\\ 0\\.006342620585540223\ \(0\)\
\-\ complicated\\:\\ 0\\.006342620585540223\ \(0\)\
\-\ experienced\\:\\ 0\\.006342620585540223\ \(0\)\
\-\ neuro\\:\\ 0\\.0063072949595168026\ \(0\)\
\-\ exercise\\:\\ 0\\.0062728206367999775\ \(0\)\
\-\ rr\\:\\ 0\\.006239157550376238\ \(0\)\
\-\ factor\\:\\ 0\\.006239157550376238\ \(0\)\
\-\ esr\\:\\ 0\\.006190103081880342\ \(0\)\
\-\ began\\:\\ 0\\.006190103081880342\ \(0\)\
\-\ smoking\\:\\ 0\\.006174118388606914\ \(0\)\
\-\ older\\:\\ 0\\.006158310325392917\ \(0\)\
\-\ date\\:\\ 0\\.006142675031355448\ \(0\)\
\-\ alert\\:\\ 0\\.006096769001954159\ \(0\)\
\-\ immediately\\:\\ 0\\.006066963441292011\ \(0\)\
\-\ nasal\\:\\ 0\\.00605229033661792\ \(0\)\
\-\ acute\\:\\ 0\\.006036850727057211\ \(0\)\
\-\ erythema\\:\\ 0\\.006009152942954562\ \(0\)\
\-\ calcium\\:\\ 0\\.005981100766433279\ \(0\)\
\-\ hr\\:\\ 0\\.005953588088424857\ \(0\)\
\-\ 17\\:\\ 0\\.005953588088424857\ \(0\)\
\-\ discharge\\:\\ 0\\.0059265945486474845\ \(0\)\
\-\ heent\\:\\ 0\\.005913286404638452\ \(0\)\
\-\ 1\\:\\ 0\\.0058178150728460856\ \(0\)\
\-\ home\\:\\ 0\\.005811056127124655\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.005774527798075778\ \(0\)\
\-\ volume\\:\\ 0\\.005774527798075778\ \(0\)\
\-\ phase\\:\\ 0\\.0057506836600425704\ \(0\)\
\-\ current\\:\\ 0\\.005727230427173219\ \(0\)\
\-\ opacity\\:\\ 0\\.005715646435424122\ \(0\)\
\-\ light\\:\\ 0\\.005704155488789981\ \(0\)\
\-\ improvement\\:\\ 0\\.005704155488789981\ \(0\)\
\-\ developmental\\:\\ 0\\.005681446834775261\ \(0\)\
\-\ t\\:\\ 0\\.005659093018032655\ \(0\)\
\-\ unable\\:\\ 0\\.0056480457417895785\ \(0\)\
\-\ discharged\\:\\ 0\\.00560469044923546\ \(0\)\
\-\ decrease\\:\\ 0\\.005594053856263332\ \(0\)\
\-\ mother\\:\\ 0\\.005583495762847563\ \(0\)\
\-\ well\\:\\ 0\\.005530989851126327\ \(0\)\
\-\ generally\\:\\ 0\\.00550172406922818\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.00550172406922818\ \(0\)\
\-\ gi\\:\\ 0\\.005491823578749533\ \(0\)\
\-\ \\'s\\:\\ 0\\.005390691325799842\ \(0\)\
\-\ until\\:\\ 0\\.005368989114362706\ \(0\)\
\-\ bp\\:\\ 0\\.005306971316260254\ \(0\)\
\-\ bleeding\\:\\ 0\\.005306971316260254\ \(0\)\
\-\ review\\:\\ 0\\.005298327089570751\ \(0\)\
\-\ resolution\\:\\ 0\\.005272703446414055\ \(0\)\
\-\ 2\\:\\ 0\\.005264962794021591\ \(0\)\
\-\ pregnancy\\:\\ 0\\.005255872485642114\ \(0\)\
\-\ good\\:\\ 0\\.0052309915947810716\ \(0\)\
\-\ relatively\\:\\ 0\\.0052309915947810716\ \(0\)\
\-\ test\\:\\ 0\\.005222793204639462\ \(0\)\
\-\ but\\:\\ 0\\.005214601719695387\ \(0\)\
\-\ suggest\\:\\ 0\\.005206536039188368\ \(0\)\
\-\ addition\\:\\ 0\\.005182491520853059\ \(0\)\
\-\ distress\\:\\ 0\\.0051510481636015916\ \(0\)\
\-\ motor\\:\\ 0\\.005105142134200304\ \(0\)\
\-\ recommended\\:\\ 0\\.005067981209445996\ \(0\)\
\-\ 9\\:\\ 0\\.005053382968853376\ \(0\)\
\-\ especially\\:\\ 0\\.005031761169411247\ \(0\)\
\-\ family\\:\\ 0\\.0050104612945990135\ \(0\)\
\-\ delayed\\:\\ 0\\.004975651422410844\ \(0\)\
\-\ placement\\:\\ 0\\.0049619612206710005\ \(0\)\
\-\ visualized\\:\\ 0\\.004948400785829021\ \(0\)\
\-\ sounds\\:\\ 0\\.004876032407019141\ \(0\)\
\-\ persistent\\:\\ 0\\.004876032407019141\ \(0\)\
\-\ 15\\:\\ 0\\.004876032407019141\ \(0\)\
\-\ complications\\:\\ 0\\.004844310150231842\ \(0\)\
\-\ progressive\\:\\ 0\\.00483181561522647\ \(0\)\
\-\ vs\\:\\ 0\\.004813276066381685\ \(0\)\
\-\ rate\\:\\ 0\\.004764980673069875\ \(0\)\
\-\ \\<\\:\\ 0\\.004718262557227168\ \(0\)\
\-\ skin\\:\\ 0\\.0046954634266652044\ \(0\)\
\-\ used\\:\\ 0\\.004689819967021404\ \(0\)\
\-\ cough\\:\\ 0\\.004684198682128858\ \(0\)\
\-\ lungs\\:\\ 0\\.0046291682374539\ \(0\)\
\-\ course\\:\\ 0\\.004613063581481604\ \(0\)\
\-\ activity\\:\\ 0\\.004586618925295477\ \(0\)\
\-\ throughout\\:\\ 0\\.004576176432474859\ \(0\)\
\-\ studies\\:\\ 0\\.004565809610556738\ \(0\)\
\-\ clear\\:\\ 0\\.004520066685474457\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.004515073259237306\ \(0\)\
\-\ intact\\:\\ 0\\.004490364265662685\ \(0\)\
\-\ abnormalities\\:\\ 0\\.004490364265662685\ \(0\)\
\-\ presence\\:\\ 0\\.004437461542857123\ \(0\)\
\-\ care\\:\\ 0\\.0044094093663358406\ \(0\)\
\-\ weight\\:\\ 0\\.004381896688327418\ \(0\)\
\-\ biopsy\\:\\ 0\\.004337186325660602\ \(0\)\
\-\ labs\\:\\ 0\\.004251751082882887\ \(0\)\
\-\ elevated\\:\\ 0\\.004147805953303381\ \(0\)\
\-\ less\\:\\ 0\\.004140114455397257\ \(0\)\
\-\ masses\\:\\ 0\\.004132464088692543\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.004132464088692543\ \(0\)\
\-\ and\\:\\ 0\\.004120377813613012\ \(0\)\
\-\ possible\\:\\ 0\\.0041172850055566125\ \(0\)\
\-\ areas\\:\\ 0\\.004113515266446447\ \(0\)\
\-\ recent\\:\\ 0\\.004109755434677821\ \(0\)\
\-\ by\\:\\ 0\\.004071161382674892\ \(0\)\
\-\ x\\:\\ 0\\.0040329990491380216\ \(0\)\
\-\ vascular\\:\\ 0\\.004008302243095417\ \(0\)\
\-\ disease\\:\\ 0\\.003996387814637208\ \(0\)\
\-\ bowel\\:\\ 0\\.003833982164355879\ \(0\)\
\-\ normal\\:\\ 0\\.0038329397842606612\ \(0\)\
\-\ will\\:\\ 0\\.003824722486951562\ \(0\)\
\-\ diffuse\\:\\ 0\\.0037010120463166164\ \(0\)\
\-\ her\\:\\ 0\\.0036758392825249437\ \(0\)\
\-\ 6\\:\\ 0\\.003651101804542023\ \(0\)\
\-\ in\\:\\ 0\\.0036171436063541194\ \(0\)\
\-\ infection\\:\\ 0\\.0035536717797894236\ \(0\)\
\-\ edema\\:\\ 0\\.0034576873954667965\ \(0\)\
\-\ all\\:\\ 0\\.0034576873954667965\ \(0\)\
\-\ time\\:\\ 0\\.003452934516794439\ \(0\)\
\-\ she\\:\\ 0\\.003431739830406541\ \(0\)\
\-\ low\\:\\ 0\\.0033993820498804\ \(0\)\
\-\ shows\\:\\ 0\\.0033610496419583386\ \(0\)\
\-\ been\\:\\ 0\\.0033258868232675124\ \(0\)\
\-\ one\\:\\ 0\\.003312920433920807\ \(0\)\
\-\ significant\\:\\ 0\\.0032873349800489602\ \(0\)\
\-\ up\\:\\ 0\\.0032873349800489602\ \(0\)\
\-\ lesions\\:\\ 0\\.003272618750134403\ \(0\)\
\-\ evidence\\:\\ 0\\.0032052111350026865\ \(0\)\
\-\ than\\:\\ 0\\.0032032172459488897\ \(0\)\
\-\ who\\:\\ 0\\.003187365392191276\ \(0\)\
\-\ on\\:\\ 0\\.0031068283792507643\ \(0\)\
\-\ to\\:\\ 0\\.0030548505611086283\ \(0\)\
\-\ increased\\:\\ 0\\.002990679230042426\ \(0\)\
\-\ associated\\:\\ 0\\.0028847819197535076\ \(0\)\
\-\ or\\:\\ 0\\.0028655872645599644\ \(0\)\
\-\ most\\:\\ 0\\.0028223678708556165\ \(0\)\
\-\ small\\:\\ 0\\.0028162736543363644\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0028071807307302145\ \(0\)\
\-\ present\\:\\ 0\\.0027610997910324474\ \(0\)\
\-\ may\\:\\ 0\\.002681442587837087\ \(0\)\
\-\ have\\:\\ 0\\.002647264775915725\ \(0\)\
\-\ treatment\\:\\ 0\\.002474416251217292\ \(0\)\
\-\ seen\\:\\ 0\\.002415776273344335\ \(0\)\
\-\ of\\:\\ 0\\.0023334094580426865\ \(0\)\
\-\ has\\:\\ 0\\.0022957081122951042\ \(0\)\
\-\ which\\:\\ 0\\.0022820380361123728\ \(0\)\
\-\ from\\:\\ 0\\.001811782136129059\ \(0\)\
\-\ ct\\:\\ 0\\.0017100195327497038\ \(0\)\
\-\ are\\:\\ 0\\.0016664862267948522\ \(0\)\
\-\ is\\:\\ 0\\.0016088434288547228\ \(0\)\
\-\ this\\:\\ 0\\.0013750174725524079\ \(0\)\
\-\ left\\:\\ 0\\.001367818697100021\ \(0\)\
\-\ year\\:\\ 0\\.001367818697100021\ \(0\)\
\-\ right\\:\\ 0\\.0012898879958661183\ \(0\)\
\-\ the\\:\\ 0\\.0011866891390869168\ \(0\)\
\-\ with\\:\\ 0\\.0011717156403851618\ \(0\)\
\-\ \\.\\:\\ 0\\.0010665096681606178\ \(0\)\
